Skip to main content

and
  1. Article

    Open Access

    Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström’s Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study

    Waldenström’s macroglobulinemia (WM) is a rare malignant B cell lymphoma which occurs in around 1–2% of all hematologic tumors. Ibrutinib was approved in China for WM on the basis of two global pivotal studies...

    Shuhua Yi, Zhen Cai, Yu Hu, Aili He, Sujun Gao, Qian Li, Linlin Sha in Advances in Therapy (2024)

  2. Article

    Open Access

    Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies

    Adipocytes and their products, adipocytokines, play important roles in the generation and development of multiple myeloma (MM). Studies have demonstrated some adipocytokines to be associated with MM, although ...

    Rui Liu, Dandan Gao, Yang Lv, Meng Zhai, Aili He in BMC Endocrine Disorders (2022)